Publications by authors named "Frances A Collichio"

Claim this Profile
A
Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description: A Retrospective Review of a Prospectively Maintained Database.
Kristen E Dougherty, Gray B Peery, Chris B Agala, Veronica P Pham, Morgan E Gwynn, Frances A Collichio

Ann Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old Man.
Shantanu Srivatsa, Collin-Jamal Smith, Omar P Sangüeza, Jayson Miedema, Frances A Collichio

Am J Dermatopathol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action.
Jacob N Stein, Jacquelyne J Gaddy, Jonathan D Sorah, Melissa Wooten, Keisha Gibson, Frances A Collichio

J Cancer Educ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
Benjamin G Vincent, Danielle M File, Karen P McKinnon, Dominic T Moore, Jeffrey A Frelinger, Frances A Collichio

J Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.
Jorge D Oldan, Benjamin C Giglio, Eric Smith, Weiling Zhao, Deeanna M Bouchard, Frances A Collichio

Oncoimmunology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
Jason A Chesney, Igor Puzanov, Frances A Collichio, Parminder Singh, Mohammed M Milhem

J Immunother Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Improving Fellow Performance of the Pharmacology Section of the American Society of Clinical Oncology In-Training Exam.
Jonathan D Sorah, Sean Clark-Garvey, Frances A Collichio

J Cancer Educ· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
Zeynep Eroglu, Kristy K Broman, John F Thompson, Amanda Nijhuis, Tina J Hieken, Frances A Collichio

J Immunother Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Georgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, Chongshan Caressi, Danny Zakria, Frances A Collichio

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study.
Jason J Bischof, Montika Bush, Rayad Bin Shams, Frances A Collichio, Timothy F Platts-Mills

Support Care Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Post Evaluation of Collaborative Oncology Palliative Care for Patients With Stage IV Cancer.
Laura C Hanson, Kathryn L Wessell, Jenny Hanspal, Feng-Chang Lin, Frances A Collichio

J Pain Symptom Manage· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality Risk for Patients With Stage IV Cancer and Acute Illness Hospitalization.
Laura C Hanson, Natalie C Ernecoff, Kathryn L Wessell, Feng-Chang Lin, Matthew I Milowsky, Frances A Collichio

J Pain Symptom Manage· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Stergios J Moschos, Zeynep Eroglu, Nikhil I Khushalani, Kari L Kendra, George Ansstas, Frances A Collichio

Melanoma Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How well do documented goals-of-care discussions for patients with stage IV cancer reflect communication best practices?
Natalie C Ernecoff, Kathryn L Wessell, William A Wood, Gary S Winzelberg, Frances A Collichio

BMC Palliat Care· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases.
Dimitri G Trembath, Eric S Davis, Shanti Rao, Evan Bradler, Angelica F Saada, Frances A Collichio

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Art of Oncology Curriculum to Mitigate Burnout and Foster Solidarity Among Hematology/Oncology Fellows.
Daniel R Richardson, Xianming Tan, Gary Winzelberg, Donald L Rosenstein, Frances A Collichio

JCO Oncol Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.
Georgia Sofia Karachaliou, Fatih Ayvali, Frances A Collichio, Carrie B Lee, Anastasia Ivanova

Oncology· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
Mazen Al Mushref, Paul A Guido, Frances A Collichio, Dominic T Moore, David R Clemmons

Endocr Pract· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.
Abdul Rafeh Naqash, Danielle M File, Carolyn M Ziemer, Young E Whang, Paula Landman, Frances A Collichio

J Immunother Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
Xiaobei Zhao, Paul Little, Alan P Hoyle, Guillaume J Pegna, Michele C Hayward, Frances A Collichio

Front Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Sandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, Dirk Schadendorf, Bartosz Chmielowski, Frances A Collichio

Invest New Drugs· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab.
Abdul R Naqash, Geoffrey Stroud, Frances A Collichio, Mahvish Muzaffar, Nitika Sharma

Acta Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials.
Howard L Kaufman, Robert H I Andtbacka, Frances A Collichio, Michael Wolf, Zhongyun Zhao

J Immunother Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Orit Kaidar-Person, Timothy M Zagar, Allison Deal, Stergios J Moschos, Matthew G Ewend, Frances A Collichio

Anticancer Drugs· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
Ana Marija Franceschi, Stergios J Moschos, Carey K Anders, Samuel Glaubiger, Frances A Collichio

J Comput Assist Tomogr· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis